FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Acitretin (Soriatane) Capsules
Status: Discontinuation
»Therapeutic Categories: Dermatology

GlaxoSmithKline (New 07/24/2017)

Company Contact Information:

Presentation Posting Date Related Information
17.5 mg capsules; 30-count bottles (NDC 0145-3817-03) 07/24/2017 A business decision was made to discontinue manufacture of the drug product. This product discontinuation is not related to product quality, safety, or efficacy. The anticipated final date of availability to patients is October 31, 2017 (NDC 0145-3817-03).

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English